Welcome to the Molecular Radiation Biology group's web pages

We investigate molecular mechanisms in radiation biology. The principal objective of the group is to discover and understand molecular mechanisms for the interaction between radiation and normal and malignant cells. We offer several research projects for master of science students and medical students.

Project groups:

Genotypes and phenotypes of malignant B-cells: The effects of ionizing radiation. (Trond Stokke).

Molecular markers for the response to radiotherapy. (Heidi Lyng).

Sommerens båttur 2007

Contact information:
Trond Stokke, Phone:+47 22 93 42 78, e-mail:tstokke@rr-research.no

Print this page [7697 visits]

Situated at:

Radiumhospitalet

News & events

The story of PCI popularized and presented in national media
May 14, 2013

Publication in Nature Genetics on testicular cancer susceptibility
May 13, 2013

Institute seminar May 8th
Gunnar Kvalheim
May 6, 2013

Llorente and coworkers publish detailed lipidomic analyses of exosomes released from prostate cancer cells
May 2, 2013

Annetine Staff appointed "Scientist of the Month" by "Helse Sør-Øst" for April 2013
Apr 30, 2013

More news

Latest publications

Molecular radiation biology

Mine KL, Shulzhenko N, Yambartsev A, Rochman M, Sanson GF, Lando M, Varma S, Skinner J, Volfovsky N, Deng T, Brenna SM, Carvalho CR, Ribalta JC, Bustin M, Matzinger P, Silva ID, Lyng H, Gerbase-Delima M, Morgun A (2013)
Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer
Nat Commun, 4, 1806
PubMed 23651994

Heyerdahl H, Abbas N, Sponheim K, Mollatt C, Bruland O, Dahle J
Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice
Curr Radiopharm (in press)
PubMed 23551111

Abbas N, Heyerdahl H, Bruland OS, Brevik EM, Dahle J
Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 Positive SKBR-3 Xenografts
Curr Radiopharm (in press)
PubMed 23551110

More publications